Upcoming Events
Boston, MA | Sept. 23-25, 2026
RNA Leaders is the #1 must-attend event focused on RNA medicines such as RNAi, antisense, non-linear RNAs, RNA editing and targeting RNA, as well as manufacturing development of mRNA therapies and vaccines.
Yokohama, Japan | October 7-9, 2026
Launched in 1986, BioJapan is Asia's premier bio-industry partnering event. As the world’s longest-running biotech exhibition, BioJapan continues to drive innovation and collaboration in the industry through its comprehensive event ecosystem, seminars, and partnering programs.
Event Calendar
Events
Calendar of Events
|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
1 event,
RNA Leaders is the #1 must-attend event focused on RNA medicines such as RNAi, antisense, non-linear RNAs, RNA editing and targeting RNA, as well as manufacturing development of mRNA therapies and vaccines. |
1 event, |
1 event, |
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
CPC SCIENTIFIC WEBINARS
Recent webinars and video content on peptide and oligonucleotide therapeutic development.
If you are currently a member, please click the button below to visit our webinar members section.
Joseph Denby, CPC Scientific
Dive into Joseph Denby's presentation at NextGen Biomed 2026, where he shares a case study on delivering sustainable, efficient peptide manufacturing on scale through our advanced SPPS process optimizations.
Sheri Ambriz, MBA, CPC Scientific
Sheri Ambriz, MBA took the stage at TIDES USA 2025 in San Diego, CA, to share insights on green approaches to peptide and peptide–oligonucleotide conjugate manufacturing.
Tim Nieters, MBA, CPC Scientific
Watch Tim Nieters, MBA present a case study at TIDES USA 2024, showcasing process development & GMP manufacturing of DOTAGA-labeled peptide & POC-based products.
Michael Verlander, D.Phil., Proactive Quality Compliance
This presentation will review new USP recommendations in the context of existing regulatory guidance, with particular focus on peptide-related impurities, their identification...
Richard Pittner, PhD, VP of Discovery Biology, Escient Pharmaceuticals Inc.
This presentation will focus on the development of the latest GLP-1 mimetics and GLP-1/GIP dual agonists, with unparalleled efficacy and ease of delivery.
John Phipps, CPC Scientific
Peptide receptor radionuclide therapy (PRRT) is a targeted therapeutic strategy that uses peptides to deliver cytotoxic radiation levels to specific receptors overexpressed in cancer cells. This case study presents a manufacturing process for DOTAGA-Labeled urea-based peptide PSMA inhibitor API, DOTAGA-(I-y)fk(Sub-KuE).
